AdaptHealth Corp. (AHCO) Misses Q2 EPS by 20c

AdaptHealth Corp. (NASDAQ: AHCO) reported Q2 EPS of $0.09, $0.20 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $727.6 million versus the consensus estimate of $724.22 million.

GUIDANCE:

AdaptHealth Corp. sees FY2022 revenue of $2.84-3.04 billion, versus the consensus of $2.96 billion.

For earnings history and earnings-related data on AdaptHealth Corp. (AHCO) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Summit Therapeutics (SMMT) Reports In-Line Q2 EPS
• World Kinect Corporation (WKC) Tops Q2 EPS by 58c; raises guidance